Re: NFK meeting
in response to
by
posted on
Feb 20, 2020 12:15PM
"We saw that the placebo part of the CKD group in the BETonMACE trial had a reduction of eGFR,..."
Where did you see this info? All I know of is the eGFR change in the total population as shown in the post-AHA corporate presentation.
BDAZ